The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cretin, N.
Right arrow Articles by Iacomini, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cretin, N.
Right arrow Articles by Iacomini, J.
The Journal of Immunology, 2002, 168: 1479-1483.
Copyright © 2002 by The American Association of Immunologists

The Role of T Cell Help in the Production of Antibodies Specific for Gal{alpha}1–3Gal1

Nathalie Cretin, Jennifer Bracy, Krista Hanson and John Iacomini2

Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The majority of xenoreactive natural Abs in humans recognize the carbohydrate Ag present on pig tissue, Gal{alpha}1–3Gal{beta}1–4GlcNAc-R ({alpha}Gal), synthesized by the enzyme UDP galactose:{beta}-D-galactosyl-1,4-N-acetyl-D-glucosaminide {alpha}(1–3)galactosyltransferase or {alpha}GT. Using {alpha}GT knockout mice (GT0 mice), which like humans produce serum Abs that bind {alpha}Gal, we examined the role of T cells in production of Abs specific for {alpha}Gal. GT0 mice were crossed with TCR-{beta} knockout mice (TCR-{beta}0) to generate double-knockout mice (GT0/TCR-{beta}0). While GT0/TCR-{beta}+ mice exhibited an age-dependent increase in the serum titer of natural Abs specific for {alpha}Gal, a similar increase was not observed in GT0/TCR-{beta}0 mice, and the titer of {alpha}Gal-specific Abs in double knockouts was significantly lower than in age-matched GT0/TCR-{beta}+ mice. Immunization with pig cells resulted in a significant increase in the serum titer of {alpha}Gal-specific Abs in GT0/TCR-{beta}+ mice, but had no effect on the level of {alpha}Gal-specific serum Abs in GT0/TCR-{beta}0 mice. Treatment of GT0/TCR-{beta}+ mice with anti-CD40L Abs before immunization with pig cells prevented sensitization to {alpha}Gal. Our data suggest that the majority of {alpha}Gal-specific Abs are T cell dependent and that production of {alpha}Gal-specific Abs after sensitization can be prevented by blocking costimulatory pathways.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Shortage of transplantable human organs has stimulated exploration into the possibility of using nonhuman donor organs for transplantation. Pigs are now regarded as the most likely species to serve as donors for clinical xenotransplantation because they are similar to humans in size and physiology, have suitable breeding characteristics, and because of ethical considerations. However, transplantation of organs between species that are phylogenetically very disparate, such as pig to primate, results in immediate Ab-mediated hyperacute rejection of the transplanted organ. In the pig-to-primate combination, 80–90% of primate xenoreactive Abs recognize the carbohydrate Ag Gal{alpha}1–3Gal{beta}1–4GlcNAc-R, hereafter referred to as {alpha}Gal (1, 2, 3). This carbohydrate epitope is synthesized by the addition of a terminal galactosyl group to a preexisting galactose residue linked to a N-acetyl-glucosaminyl structure, and is catalyzed by the glucosyltransferase UDP galactose:{beta}-D-galactosyl-1,4-N-acetyl-D-glucosaminide {alpha}(1, 2, 3)galactosyltransferase (EC 2.4.1.151), or {alpha}GT. As many as 106 to 107 {alpha}Gal epitopes can be expressed on the surface of pig cells and tissues (4). In humans, {alpha}Gal-specific Abs comprise ~1–8% of circulating Ig, and it has been shown that approximately 1% of EBV-transformed peripheral blood B cells make Abs that bind {alpha}Gal (5, 6).

Abs specific for {alpha}Gal are produced in the host without intentional immunization and are termed natural Abs. Production of natural Abs specific for {alpha}Gal is thought to occur following exposure to bacteria that colonize the gastrointestinal tract (7, 8). The presence of these Abs in serum and secretory fluids, such as colostrum and saliva, suggests that these Abs have evolved to play a protective role in primate immunity. Enveloped viruses produced in {alpha}Gal-expressing animal cells, such as lymphocytic choriomeningitis virus, Newcastle disease virus, and vesicular stomatitis virus, as well as C-type retroviruses, have all been shown to be susceptible to inactivation by {alpha}Gal-specific Abs in serum. {alpha}Gal-modified host cell surface proteins are incorporated into virus envelopes, which renders the virus susceptible to elimination by {alpha}Gal-specific Abs (9, 10).

In humans, {alpha}Gal-specific Abs appear to be encoded for by a restricted set of Ig VH genes from the VH3 family (11). More recently, the development of knockout mice lacking the enzyme UDP galactose:{beta}-D-galactosyl-1,4-N-acetyl-D-glucosaminide {alpha}(1, 2, 3)galactosyltransferase, the enzyme that generates the {alpha}Gal epitope, has made it possible to study regulation of {alpha}Gal Ab production in a small animal model (12, 13), because {alpha}GT knockout mice (GT0 mice), like humans, produce Abs specific for {alpha}Gal (14). Recently, the analysis of a small number of B cell hybridomas isolated from immunized GT0 mice revealed that Abs specific for {alpha}Gal appear to exhibit restricted V region gene usage (15). Interestingly, somatic mutations were observed in the VH genes utilized by these hybridomas as well as human VH genes encoding {alpha}Gal-specific Abs (11). The presence of somatic mutations is surprising because {alpha}Gal-specific Abs are thought to be largely T cell independent due to the structural nature of the epitope on glycoproteins and glycolipids, which should allow efficient cross-linking of the B cell Ag receptor. Insofar as Ig somatic hypermutation requires T cell involvement (16), the presence of somatic mutations suggests that Abs specific for {alpha}Gal may have a T cell-dependent component.

Using GT0 mice, we examined the requirement for {alpha}{beta} T cells in the production of {alpha}Gal-specific Abs. To this end, GT0 mice were mated to TCR-{beta}-deficient mice (17) to generate double-knockout mice (GT0/TCR-{beta}0). We then compared the ability of GT0/TCR-{beta}0 and GT0/TCR-{beta}+ mice to produce {alpha}Gal-specific natural Abs. Our data suggest that the majority of {alpha}Gal-specific natural Abs that develop over time and Abs produced following sensitization to pig cells are T cell dependent. Furthermore, production of {alpha}Gal-specific Abs following immunization with pig cells can be prevented by blocking the interaction of CD40 and CD40L.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

The breeding of GT0 mice for these studies is described previously (18). TCR-{beta} knockout mice on the C57BL/6 background were obtained from The Jackson Laboratory (Bar Harbor, ME) and mated with H-2b GT0 mice. All experiments were conducted using mice between 6 and 8 wk of age. C57BL/6SnJ mice were used as GT+ controls, and were obtained from The Jackson Laboratory. All mice were housed in autoclaved microisolator conditions and maintained on irradiated feed and autoclaved acidified drinking water.

Immunization

Heparinized pig blood was collected from miniature swine from the Massachusetts General Hospital herd housed at the Tufts University School of Veterinary Medicine (North Grafton, MA) (19). PBMC were purified from pig blood, as described previously (20). Mice were immunized i.p. with 107 irradiated (2500 rad) pig PBMC (pPBMC).3 Immunization with Streptococcus pneumoniae strain R36A was conducted as described previously (21). The multivalent polymer Gal{alpha}1–3Gal{beta}1–4GlcNAc{beta}-polyacrylamide ({alpha}Gal-PAA) was used as a T cell-independent type 2 Ag in this study, and was purchased from GlycoTech (Rockville, MD). {alpha}Gal-PAA consists of a multivalent PAA polymer of approximately 30 kDa containing 20% carbohydrate on a molar basis. Mice were immunized i.p. with 100 µg {alpha}Gal-PAA dissolved in normal saline at approximately 8 wk of age. Mice were immunized 3 wk later, and the serum titer of {alpha}Gal-specific Abs was determined by ELISA at days 5 and 10 following the second immunization.

Flow cytometry

Cell surface staining of peripheral blood, flow cytometry, and analyses were performed as described previously (22). {alpha}Gal epitopes were detected using the {alpha}Gal-specific IB4 lectin from Bandeiraea simplicifolia (BS-I isolectin B4) (23). T cells were detected using the mAb H57-597, which recognizes all {alpha}{beta} TCRs (24)

Enzyme-linked immunosorbent assay

ELISAs were conducted as described previously (22). Briefly, ELISA plates (Corning, Corning, NY) were coated overnight at 4°C with either {alpha}Gal conjugated to BSA or lactosamine conjugated to BSA (Lac-BSA; V-Labs, Covington, LA) in carbonate buffer (pH 9.5), and then washed with PBS containing 0.05% Tween 20 (PBS-Tween). Lac-BSA shares all determinants with {alpha}Gal-BSA, except for the terminal galactose structure, and serves as a specificity control. The wells were blocked with 1% BSA in PBS-Tween for 1 h at room temperature and then washed. Serum samples were serially diluted in PBS-Tween, added to the plates, and incubated for 1 h at 37°C. The plates were then washed extensively with PBS-Tween, and bound Abs were detected using HRP-conjugated goat anti-mouse IgM. The plates were incubated for 1 h at 37°C and then washed five times with PBS-Tween. A total of 0.01 mg/ml o-phenylenediamine dihydrochloride in substrate buffer was then added for 20 min at room temperature to develop the assays. The reaction was terminated by adding H2SO4 to each well, and absorbency was read at 492 nm. Background values obtained from Lac-BSA-coated plates were subtracted from those obtained using Gal-BSA-coated plates. Assays were performed in duplicate. The titer of phosphorylcholine (PC)-specific Abs following immunization with S. pneumoniae was determined as described previously (21).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A requirement for {alpha}{beta} T cells in production of {alpha}Gal-specific natural Abs

To determine the role of T cells in production of {alpha}Gal-specific natural Abs, GT0 mice were crossed with TCR-{beta} knockout mice (17). Offspring were then intercrossed to generate {alpha}GT-TCR-{beta} double knockouts (GT0/TCR-{beta}0 mice). Double knockouts identified by staining of peripheral blood cells for expression of {alpha}Gal and mature {alpha}{beta} T cells, followed by flow cytometry, were then intercrossed to establish a colony of GT0/TCR-{beta}0 mice (Fig. 1Go). Starting at 5 wk of age, GT0/TCR-{beta}0, GT0/TCR-{beta}+, as well as GT+/TCR-{beta}+ normal controls were bled every other week, and sera were analyzed for the presence of Abs capable of binding to gal{alpha}(1, 3)gal-conjugated to BSA ({alpha}Gal-BSA) by ELISA. Binding of serum Abs to Lac-BSA, an Ag that shares all determinants with {alpha}Gal-BSA except for the terminal galactose, was examined in parallel to confirm that Ab binding to {alpha}Gal-BSA was specific. IgM Abs were studied because we have observed that in GT0 mice IgM Abs make up the majority of {alpha}Gal-specific Abs (our unpublished observation). At 5 wk of age, low levels of {alpha}Gal-specific serum Abs were detectable in the sera of GT0/TCR-{beta}0 and GT0/TCR-{beta}+ mice (Fig. 2Go). As expected, {alpha}Gal-specific Abs were not detected in GT+/TCR-{beta}+ or GT+/TCR-{beta}0 (TCR knockouts) at any time analyzed (not shown). While GT0/TCR-{beta}+ mice exhibited an age-dependent increase in the serum titer of {alpha}Gal-specific Abs apparent by 14 wk of age, a similar increase was not observed in GT0/TCR-{beta}0 mice (Fig. 2Go). Similar results were observed at 22 wk of age (not shown). These data suggest that an age-dependent increase in the level of {alpha}Gal-specific serum natural Ab is largely T cell dependent.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 1. Characterization of GT0/TCR-{beta}0 mice by flow cytometry. Shown is the pattern of TCR-{alpha}{beta} vs {alpha}Gal staining on peripheral blood cells from GT+/TCR-{beta}+ (left), GT0/TCR-{beta}+ (center), and GT0/TCR-{beta}0 (right) mice. Samples from representative mice are shown. T cells in mice express low levels of {alpha}Gal epitopes on their cell surface (J. Bracy, N. Cretin, and J. Iacomini, unpublished observation).

 


View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 2. {alpha}Gal-reactive natural Ab secretion is T cell dependent. Shown is the ELISA analysis of {alpha}Gal-reactive natural serum IgM Ab production in GT0/TCR-{beta}+ ({circ} and •) and GT0/TCR-{beta}0 ({square} and {blacksquare}) mice at 5 (• and {blacksquare}) and 14 ({circ} and {square}) wk of age. Shown are the mean values and SD for each group (n = 5 mice per group) from a representative experiment. All samples were assayed in duplicate.

 
Production of {alpha}Gal-specific Abs following pig cell immunization is T cell dependent

We next examined the role of {alpha}{beta} T cells in the production of {alpha}Gal-specific Abs following exposure to pig cells. To this end, 8-wk-old GT0/TCR-{beta}0, GT0/TCR-{beta}+, and GT+/TCR-{beta}+ mice were immunized i.p. with 107 irradiated pPBMC. Ten days later, the mice were reimmunized, and 2 wk after the second immunization the mice were bled and sera were analyzed for the presence of {alpha}Gal-specific Abs by ELISA. As expected based on our previous work (22), following immunization with pPBMC, GT0/TCR-{beta}+ exhibited a significant increase in {alpha}Gal-specific Ab titer, while {alpha}Gal-specific Abs were undetectable in the serum of immunized GT+/TCR-{beta}+ controls (Fig. 3Go). In contrast, immunization of GT0/TCR-{beta}0 did not lead to a significant increase in serum {alpha}Gal-specific Ab titer (Fig. 3Go). The level of {alpha}Gal-specific Ab in GT0/TCR-{beta}0 was essentially unchanged from that observed before immunization. These data suggest that anti-{alpha}Gal Ab production following exposure to pig cells is T cell dependent.



View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 3. Pig cell sensitization elicits T cell-dependent {alpha}Gal-reactive Abs. Analysis of {alpha}Gal-reactive serum IgM Ab production in GT0/TCR-{beta}+ ({blacktriangleup}) and GT0/TCR-{beta}0 (•) mice after immunization with pPBMC by ELISA. Shown are the mean values and SD for each group from a representative experiment. All samples were assayed in duplicate.

 
Immunization of GT0/TCR-{beta}0 mice with T cell-independent type 2 Ags containing {alpha}Gal structures

To directly determine the extent to which T cell-independent Abs can contribute to a response to {alpha}Gal, age-matched GT0/TCR-{beta}0 and GT0/TCR-{beta}+ mice were immunized i.p. with a T cell-independent type 2 Ag, {alpha}Gal conjugated to polyacrylamide ({alpha}Gal-PAA). Repeated immunization of either GT0/TCR-{beta}0 or GT0/TCR-{beta}+ mice with {alpha}Gal-PAA led to only a modest increase in the serum titer of {alpha}Gal-specific Abs (Fig. 4GoA). Similar results were obtained following i.v. immunization (not shown).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 4. Responses of GT0/TCR-{beta}0 mice after immunization with T cell-independent Ags expressing {alpha}Gal. A, Analysis of {alpha}Gal-specific serum IgM in GT0/TCR-{beta}+ ({square}, {circ}, and {diamond}) and GT0/TCR-{beta}0 ({blacksquare}, •, and {diamondsuit}) mice (n = 5 per group) after immunization with {alpha}Gal-PAA by ELISA. {diamond} and {diamondsuit}, Serum titer of {alpha}Gal-reactive Ab preimmunization; {circ} and •, serum titers on day 5 after immunization; {square} and {blacksquare}, serum titers on day 10 after immunization. B, Production of Abs specific for PC after immunization of GT0/TCR-{beta}+ ({blacksquare}, •, and {diamondsuit}) and GT0/TCR-{beta}0 ({square}, {circ}, and {diamond}) mice (n = 6 per group) with S. pneumoniae strain R36A. {diamond}, Serum titer of {alpha}Gal-reactive Ab before immunization; {circ} and •, serum titers on day 4 after immunization; {square} and {blacksquare}, serum titers on day 15 after immunization. Shown are the mean values and SD for each group in a representative experiment.

 
To further examine the ability of GT0/TCR-{beta}0 and GT0/TCR-{beta}+ mice to respond to T cell-independent type 2 Ags, mice were immunized with heat-killed S. pneumoniae strain R36A, and the ability to make Abs specific for PC was examined by ELISA. Following immunization with S. pneumoniae, both GT0/TCR-{beta}0 and GT0/TCR-{beta}+ mice were able to make a robust response to PC (Fig. 4GoB). Therefore, GT0/TCR-{beta}0 and GT0/TCR-{beta}+ mice are capable of making Ab responses to T cell-independent Ags. Insofar as immunization with {alpha}Gal-PAA did not lead to a significant increase in the titer of {alpha}Gal-specific serum Abs, while pig cell immunization did, we suggest that {alpha}Gal-specific Abs are predominantly T cell dependent.

Costimulatory blockade prevents sensitization to {alpha}Gal

The results of our experiments strongly suggested that production of {alpha}Gal-specific Abs is predominantly T cell dependent. We therefore sought to examine whether inhibiting T cell responses using costimulatory blockade could affect the ability of GT0/TCR-{beta}+ mice to make a response to {alpha}Gal following immunization with pig cells. To this end, GT0/TCR-{beta}+ mice were treated with 0.1 mg anti-CD154 mAb (MR1 (25)) in saline on days -3 and -1 relative to immunization with 106 irradiated pPBMC. The mice received a third dose on day 3 after immunization. As expected, control mice treated with saline alone exhibited a significant increase in the serum titer of {alpha}Gal-specific Abs following pig cell immunization (Fig. 5Go). In contrast, GT0/TCR-{beta}+ mice receiving anti-CD154 mAb failed to exhibit a significant increase in the serum titer of {alpha}Gal-specific Abs following pig cell immunization (Fig. 5Go). Thus, costimulatory blockade prevents production of {alpha}Gal-specific Abs following exposure to pig cells.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 5. Costimulatory blockade prevents sensitization to {alpha}Gal following exposure to pig cells. Analysis of {alpha}Gal-reactive serum IgM Ab production in GT0/TCR-{beta}+ mice treated with anti-CD154 ({blacksquare}, •, and {diamondsuit}) or saline ({square}, {circ}, and {diamond}) after immunization with pPBMC by ELISA. {square} and {blacksquare}, Serum titer of {alpha}Gal-reactive Abs before immunization; {circ} and •, responses on day 7 after immunization; {diamond} and {diamondsuit}, responses on day 14 after immunization; . Shown is one representative experiment of two. Shown are the mean values and SD for each group (n = 5 mice per group).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Abs specific for {alpha}Gal represent the major immunological hurdle to successful transplantation of pig organs and tissues into humans, and are thought to play a role in host immunity to various pathogens. Yet, very little is known about how production of Abs specific for {alpha}Gal is regulated. Using GT0 mice, we examined the role of {alpha}{beta} T cells in the production of {alpha}Gal-specific Abs. Immunization with pig cells was able to elicit production of {alpha}Gal-specific Abs in GT0 mice only when {alpha}{beta} T cells were present. Immunization with T cell-independent Ags containing the {alpha}Gal epitope had little effect on the serum level of {alpha}Gal-specific Abs. Furthermore, costimulatory blockade was able to completely inhibit production of {alpha}Gal-specific Abs following sensitization with pig cells. Together, these data suggest that the majority of natural Abs produced in GT0 mice are T cell dependent.

Based on the structural nature of the {alpha}Gal Ag on glycoproteins and glycolipids, and the observation that IgM {alpha}Gal Ab is the predominant Ig involved in in vitro cytotoxicity to pig cells as well as hyperacute rejection (reviewed in Ref. 26), it has been thought that T cell-independent Abs make up a significant fraction of the response to {alpha}Gal. However, the observation that somatic mutations are present in VH genes utilized by hybridomas making {alpha}Gal-specific IgM Abs isolated from GT0 mice (15), and human VH genes encoding {alpha}Gal-specific Abs (11), has called for a reexamination of the T cell independence of these Abs because Ig somatic hypermutation requires T cell involvement (16). Recent evidence in rodent models suggesting a role of T cells in production of {alpha}Gal-specific Abs has been indirect, inferred based on the isotype composition of elicited Abs following sensitization, and the effect of nondepleting anti-CD4 Abs on survival of {alpha}Gal expressing allo- and xenogeneic hearts (27, 28). The genetic approach presented in this work suggests that IgM Abs specific for {alpha}Gal are T cell dependent.

Although the majority of {alpha}Gal-specific Ab is T cell dependent, we were able to observe a small amount of {alpha}Gal-specific natural Ab in T cell-deficient GT0 mice. While production of this Ab is clearly independent of {alpha}{beta} T cells in these mice, it is not clear whether {gamma}{delta} T cells could be involved in its production. {gamma}{delta} T cells have been implicated in providing help to B cells, particularly after certain types of infections are initiated (29). Thus, it is possible that in the absence of {alpha}{beta} T cells, infections involving stimulation of {gamma}{delta} T cells could lead to B cell activation and production of {alpha}Gal-specific Abs, as observed in other systems (30). The mice used in this study were housed in microisolator conditions, which affects their exposure to various flora and may influence production of Abs specific for {alpha}Gal. We are currently examining the role of {gamma}{delta} T cells in the production of {alpha}Gal-specific Abs after infection, and whether exposure to various pathogens can affect the T cell dependence of {alpha}Gal-specific Abs.

Inhibition of the interaction of CD40 and CD154 completely prevented production of {alpha}Gal-specific Abs in vivo after immunization with pig cells. Given that the interaction of CD40 and CD154 is required for T cell-dependent immune responses (31), these results support our hypothesis that {alpha}Gal-specific Ab production is T cell dependent. These results also have implications for xenotransplantation, because sensitization to {alpha}Gal following exposure to pig tissues could be overcome by blocking the interaction of CD40 and CD154. Consistent with this notion, it has been shown in baboons that preconditioning with a combination of whole body and thymic irradiation, extracorporeal immunoadsorption of {alpha}Gal Ab, mycophenolate mofetil, antithymocyte globulin, and anti-CD154 leads to humoral hyporesponsiveness following infusion of cytokine-mobilized pig blood cells (32). Indeed, the observation that {alpha}Gal-specific Ab production is T cell dependent suggests that T cell immunosuppression will be a major part of host preparation for xenotransplantation.


    Acknowledgments
 
We thank Drs. David H. Sachs and D. K. C. Cooper for critically reading the manuscript, members of the Iacomini laboratory for helpful discussions, Dr. John Kearney (University of Alabama, Birmingham, AL) for providing us with S. pneumoniae strains R36A and PC-BSA, and Dr. Megan Sykes for providing MR1.


    Footnotes
 
1 This work was supported by Grant RO1 AI44268 from the National Institutes of Health (to J.I.); grants from the Swiss National Fund (to N.C.), the Foundation Eugenio Litta (to N.C.), and the M. Seidl-Hentsch Foundation (to N.C.); and in part by National Institutes of Health Training Grant T32 AI07529 (to J.B.). Back

2 Address correspondence and reprint requests to Dr. John Iacomini, Transplantation Biology Research Center, Massachusetts General Hospital, MGH-East, Building 149, 13th Street, Boston, MA 02129. Back

3 Abbreviations used in this paper: pPBMC, pig PBMC; Lac, lactosamine; PAA, polyacrylamide; PC, phosphorylcholine. Back

Received for publication August 8, 2001. Accepted for publication November 20, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Good, A. H., D. K. C. Cooper, A. J. Malcolm, R. M. Ippolito, E. Koren, F. A. Neethling, Y. Ye, N. Zuhdi, L. R. Lamontagne. 1992. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. 24:559.[Medline]
  2. Oriol, R., Y. Ye, E. Koren, D. K. Cooper. 1993. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 56:1433.[Medline]
  3. Sandrin, M. S., H. A. Vaughan, P. L. Dabkowski, I. F. McKenzie. 1993. Anti-pig IgM antibodies in human serum react predominantly with Gal({alpha} 1–3)Gal epitopes. Proc. Natl. Acad. Sci. USA 90:11391.[Abstract/Free Full Text]
  4. Galili, U., S. B. Shohet, E. Kobrin, C. L. M. Stults, B. A. Macher. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of {alpha}-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263:17755.[Abstract/Free Full Text]
  5. Galili, U., F. Anaraki, A. Thall, C. Hill-Black, M. Radic. 1993. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 82:2485.[Abstract/Free Full Text]
  6. McMorrow, I. M., C. A. Comrack, D. H. Sachs, H. DerSimonian. 1997. Heterogeneity of human anti-pig natural antibodies cross-reactive with the gal({alpha}1,3)galactose epitope. Transplantation 64:501.[Medline]
  7. Galili, U., R. E. Mandrell, R. M. Hamadeh, S. B. Shohet, J. M. Griffiss. 1988. Interaction between human natural anti-{alpha}-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56:1730.[Abstract/Free Full Text]
  8. Hamadeh, R. M., G. A. Jarvis, U. Galili, R. E. Mandrell, P. Zhou, J. M. Griffiss. 1992. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Invest. 89:1223.
  9. Welsh, R. M., C. L. O’Donnell, D. J. Reed, R. P. Rother. 1998. Evaluation of the Gal {alpha}1–3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses. J. Virol. 72:4650.[Abstract/Free Full Text]
  10. Takeuchi, Y., C. D. Porter, K. M. Strahan, A. F. Preece, K. Gustafsson, F.-L. Cosset, R. A. Weiss, M. K. L. Collins. 1996. Sensitization of cells and retroviruses to human serum by ({alpha}1–3)galactosyltransferase. Nature 379:85.[Medline]
  11. Wang, L., M. Z. Radic, U. Galili. 1995. Human anti-Gal heavy chain genes: preferential use of VH3 and the presence of somatic mutations. J. Immunol. 155:1276.[Abstract]
  12. Thall, A. D., P. Maly, J. B. Lowe. 1995. Oocyte Gal {alpha}1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270:21437.[Abstract/Free Full Text]
  13. Tearle, R. G., M. J. Tange, Z. L. Zannettino, M. Katerelos, T. A. Shinkel, B. J. Van Denderen, A. J. Lonie, I. Lyons, M. B. Nottle, T. Cox, et al 1996. The {alpha}-1,3-galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation 61:13.[Medline]
  14. Thall, A., H. Murphy, J. B. Lowe. 1996. {alpha}1,3-Galactosyltransferase deficient mice produce cytotoxic natural anti-Gal antibodies. Transplant. Proc. 28:561.[Medline]
  15. Chen, Z. C., M. Z. Radic, U. Galili. 2000. Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in {alpha}1,3galactosyltransferase knock out mice. Mol. Immunol. 37:455.[Medline]
  16. Williams, G. T., C. J. Jolly, J. Kohler, M. S. Neuberger. 2000. The contribution of somatic hypermutation to the diversity of serum immunoglobulin: dramatic increase with age. Immunity 13:409.[Medline]
  17. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, S. Tonegawa. 1992. Mutations in T-cell antigen receptors {alpha} and {beta} block thymocyte development at different stages. Nature 360:225.[Medline]
  18. Bracy, J. L., D. H. Sachs, J. Iacomini. 1998. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 281:1845.[Abstract/Free Full Text]
  19. Sachs, D. H.. 1992. MHC homozygous miniature swine. M. M. Swindle, and D. C. Moody, and L. D. Phillips, eds. Swine as Models in Biomedical Research 1st Ed.3. Iowa State University Press, Ames.
  20. Sawada, T., P. A. DellaPelle, J. D. Seebach, D. H. Sachs, R. B. Colvin, J. Iacomini. 1997. Human cell-mediated rejection of porcine xenografts in an immunodeficient mouse model. Transplantation 63:1331.[Medline]
  21. Mombaerts, P., E. Mizoguchi, H. Ljunggren, J. Iacomini, H. Ishikawa, L. Wang, M. Grusby, L. H. Glimcher, H. J. Winn, A. K. Bhan, S. Tonegawa. 1994. Peripheral lymphoid development and function in TCR mutant mice. Int. Immunol. 6:1061.[Abstract/Free Full Text]
  22. Bracy, J. L., J. Iacomini. 2000. Induction of B cell tolerance by retroviral gene therapy. Blood 96:3008.[Abstract/Free Full Text]
  23. Wood, C., E. A. Kabat, L. A. Murphy, I. J. Goldstein. 1979. Immunochemical studies of the combining sites of the two isolectins, A4 and B4, isolated from Bandeiraea simplicifolia. Arch. Biochem. Biophys. 198:1.[Medline]
  24. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine {alpha}{beta} T cell receptors. J. Immunol. 142:2736.[Abstract]
  25. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.[Abstract/Free Full Text]
  26. Kobayashi, T., D. K. C. Cooper. 1999. Anti-gal, {alpha}-gal epitopes, and xenotransplantation. U. Galili, and J. L. Avila, eds. {alpha}-Gal and Anti-Gal: {alpha}1,3-Galactosyltransferase, {alpha}-Gal Epitopes, and the Natural Anti-Gal Antibody 229. Kluwer Academic/Plenum Publishers, New York.
  27. Chong, A., L. Blinder, L. Ma, D. Yin, J. Shen, J. W. Williams, G. Byrne, A. Schwarz, L. S. Diamond, J. E. Logan. 2000. Anti-galactose-{alpha}(1, 3) galactose antibody production in {alpha}1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transplant Immunol. 8:129.[Medline]
  28. Chong, A. S., L. Ma, D. Yin, J. Shen, L. Blinder, X. XiuLong, J. W. Williams, G. Byrne, L. E. Diamond, J. S. Logan. 2000. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in {alpha}1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation 7:275.[Medline]
  29. Wen, L., A. C. Hayday. 1997. {gamma}{delta} T-cell help in responses to pathogens and in the development of systemic autoimmunity. Immunol. Res. 16:229.[Medline]
  30. Smith, A. L., A. C. Hayday. 2000. An {alpha}{beta} T-cell-independent immunoprotective response towards gut coccidia is supported by {gamma}{delta} cells. Immunology 101:325.[Medline]
  31. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.[Abstract/Free Full Text]
  32. Buhler, L., M. Awwad, M. Basker, S. Gojo, A. Watts, S. Treter, K. Nash, G. Oravec, Q. Chang, A. Thall, et al 2000. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 69:2296.[Medline]



This article has been cited by other articles:


Home page
Poult. Sci.Home page
H. K. Parmentier, G. De Vries Reilingh, and A. Lammers
Decreased Specific Antibody Responses to {alpha}-Gal-Conjugated Antigen in Animals with Preexisting High Levels of Natural Antibodies Binding {alpha}-Gal Residues
Poult. Sci., May 1, 2008; 87(5): 918 - 926.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Benatuil, J. Kaye, N. Cretin, J. G. Godwin, A. Cariappa, S. Pillai, and J. Iacomini
Ig Knock-In Mice Producing Anti-Carbohydrate Antibodies: Breakthrough of B Cells Producing Low Affinity Anti-Self Antibodies
J. Immunol., March 15, 2008; 180(6): 3839 - 3848.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Shimizu, T. Kawahara, F. Haspot, P. D. Bardwell, M. C. Carroll, and M. Sykes
B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-{alpha}GAL-producing B-1 cells
Blood, February 15, 2007; 109(4): 1773 - 1781.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mitsuhashi, J. Fischer-Lougheed, I. Shulkin, A. Kleihauer, D. B. Kohn, K. I. Weinberg, V. A. Starnes, and M. Kearns-Jonker
Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen
Blood, March 15, 2006; 107(6): 2286 - 2293.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kawahara, H. Ohdan, G. Zhao, Y.-G. Yang, and M. Sykes
Peritoneal Cavity B Cells Are Precursors of Splenic IgM Natural Antibody-Producing Cells
J. Immunol., November 15, 2003; 171(10): 5406 - 5414.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. M. Mohiuddin, H. Ogawa, D.-P. Yin, and U. Galili
Tolerance induction to a mammalian blood group--like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells
Blood, July 1, 2003; 102(1): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. J. Posekany, H. K. Pittman, J. F. Bradfield, C. E. Haisch, and K. M. Verbanac
Induction of Cytolytic Anti-Gal Antibodies in {alpha}-1,3-Galactosyltransferase Gene Knockout Mice by Oral Inoculation with Escherichia coli O86:B7 Bacteria
Infect. Immun., November 1, 2002; 70(11): 6215 - 6222.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cretin, N.
Right arrow Articles by Iacomini, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cretin, N.
Right arrow Articles by Iacomini, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS